← Every applicant
Xiromed FDA Approvals
19 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CLOBETASOL PROPIONATENew drugNov 20, 2025AEROSOL, FOAM, TOPICAL |
| PROGESTERONENew drugSep 19, 2025INSERT, VAGINAL |
| METHYLENE BLUENew drugJul 30, 2025SOLUTION, INTRAVENOUS |
| CETRORELIX ACETATENew drugJun 3, 2025POWDER, SUBCUTANEOUS |
| LEVOTHYROXINE SODIUMNew drugNov 29, 2024POWDER, INTRAVENOUS |
| GUANFACINE HYDROCHLORIDENew drugFeb 23, 2024TABLET, ORAL |
| LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATENew drugAug 16, 2023TABLET, ORAL |
| ENILLORINGNew drugJun 29, 2023RING, VAGINAL |
| ESTRADIOL VALERATENew drugApr 28, 2023INJECTABLE, INJECTION |
| BETAMETHASONE VALERATENew drugApr 18, 2023AEROSOL, FOAM, TOPICAL |
| TESTOSTERONE CYPIONATENew drugApr 13, 2023INJECTABLE, INJECTION |
| RAMELTEONNew drugNov 25, 2022TABLET, ORAL |
| ESTRADIOLNew drugAug 10, 2022GEL, TRANSDERMAL |
| EPHEDRINE SULFATENew drugApr 21, 2022SOLUTION, INTRAVENOUS |
| PROGESTERONENew drugJan 5, 2022INJECTABLE, INJECTION |
| CYANOCOBALAMINNew drugAug 20, 2021INJECTABLE, INJECTION |
| FULVESTRANTNew drugAug 13, 2021SOLUTION, INTRAMUSCULAR |
| KETOCONAZOLENew drugMay 21, 2021AEROSOL, FOAM, TOPICAL |
| GLYCOPYRROLATENew drugMar 4, 2021INJECTABLE, INJECTION |